Evansbrook’s Medtronic MDT Stock Holding History

Evansbrook’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440K	Hold	5,622	–	–	0.26%	76
2026 Q1	$487K	Buy	+5,622	New	+$539K	0.33%	70

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Evansbrook's MDT Position: Q2 2026 in Review

Evansbrook held its Medtronic (MDT) position steady in Q2 2026 at 5,622 shares worth $440K. The position accounts for 0.26% of the portfolio, ranked #76.

Evansbrook first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $487K in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Evansbrook held 5,622 shares of Medtronic worth $440K as of Q2 2026.
Evansbrook left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.26% of Evansbrook's portfolio in Q2 2026, its #76 holding.
Evansbrook first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
Evansbrook's Medtronic position peaked at $487K in Q1 2026.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Evansbrook's 13F filing for Q2 2026, filed 4 Aug 2026.